Giri Sulur
-
- Prostate Cancer Treatment and Research 9
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 2
-
- Hormonal and reproductive studies 4
-
- Radiopharmaceutical Chemistry and Applications 8
-
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 2
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Kim N.Mustafa ÖzgüroğluKarim FizaziLuis FeinAndrew ProtheroeSusan FeyerabendSusan LiNobuaki Matsubara
- Journals
- Journal of Clinical Oncology (9 papers)SHILAP Revista de lepidopterología (1 paper)Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Giri Sulur
17 papers receiving 785 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 587
- Cancer Research 199
- Endocrinology, Diabetes and Metabolism 189
- Radiology, Nuclear Medicine and Imaging 216
- Hematology 67
Countries citing papers authored by Giri Sulur
This map shows the geographic impact of Giri Sulur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giri Sulur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giri Sulur more than expected).
Fields of papers citing papers by Giri Sulur
This network shows the impact of papers produced by Giri Sulur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giri Sulur. The network helps show where Giri Sulur may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Giri Sulur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 10 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 20 | |
| 8 | 2019 | 78 | |
| 9 | Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trialbreakdown → | 2019 | 517 |
| 10 | 2019 | 8 | |
| 11 | 2018 | 4 | |
| 12 | 2018 | 7 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 0 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2009 | 8 | |
| 18 | 2008 | 90 | |
| 19 | 2003 | 40 |
About Giri Sulur
Giri Sulur is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 19 papers that have together received 796 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Hormonal and reproductive studies (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (587 citations), Cancer Research (199 citations) and Endocrinology, Diabetes and Metabolism (189 citations). Giri Sulur has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Kim N., Mustafa Özgüroğlu, Karim Fizazi, Luis Fein, Andrew Protheroe, Susan Feyerabend, Susan Li, Nobuaki Matsubara, A. Rodrı́guez-Antolı́n and Suneel Mundle. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.